Vision Loss Impact on Navigation in Virtual Reality (NCT06047717) | Clinical Trial Compass
RecruitingNot Applicable
Vision Loss Impact on Navigation in Virtual Reality
United States40 participantsStarted 2023-11-28
Plain-language summary
The purpose of this research is to better understand the impact of cortically-induced blindness (CB) and the compensatory strategies subjects with this condition may develop on naturalistic behaviors, specifically, driving. Using a novel Virtual Reality (VR) program, the researchers will gather data on steering behavior in a variety of simulated naturalistic environments. Through the combined use of computer vision, deep learning, and gaze-contingent manipulations of the visual field, this work will test the central hypothesis that changes to visually guided steering behaviors in CB are a consequence of changes to the visual sampling and processing of task-related motion information (i.e., optic flow).
Who can participate
Age range21 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cortically Blind Group:
Inclusion Criteria:
* Residents of the United States or Canada
* Presence of one-sided stroke or stroke-like damage to primary visual cortex or its immediate afferent white matter sustained within the specified age range of 21 - 75 years (verified by MRI and/or CT scans)
* Reliable visual field defects in both eyes (homonymous defects) as measured by Humphrey or equivalent perimetry.
* Willing, able, and competent to provide their own informed consent
* Cognitively able, responsible to understand written and oral instructions in English
* Emmetropic or else wear corrective contact lenses inside the virtual reality headset
Exclusion Criteria:
* Those who have never driven or earned a drivers' license
* Past or present ocular disease interfering with visual acuity
* Best corrected visual acuity (BCVA) worse than 20/40 in either eye
* Sustained damage to the dorsal lateral geniculate nucleus
* Presence of diffuse, whole-brain degenerative processes
* Presence of brain damage deemed by study staff to potentially interfere with outcome measures
* History of traumatic brain injury
* Documented history of drug/alcohol abuse
* Diagnosis of cognitive or seizure disorders
* Diagnosis of one-sided attentional neglect
Control Group:
Inclusion Criteria:
* Normal or corrected-to-normal vision, who are between the ages of 21 and 75 years of age, roughly matched to the age of CB subjects enrolled above
* Competent and responsible, as determined by the Principal…